Our vaccine vs the rest: We are highly specific
Post# of 36536
(Total Views: 279)
Posted On: 04/30/2020 10:48:04 AM
Our vaccine vs the rest:
We are highly specific Th1 T cell and B cell activation toward portions of SARS-CoV-2 proteins for which their is very good evidence of protection. No one else has this. Everyone else is doing sub unit vaccines, for which there is very good evidence that portions of those sub units trigger disease enhancement.
We are highly specific Th1 T cell and B cell activation toward portions of SARS-CoV-2 proteins for which their is very good evidence of protection. No one else has this. Everyone else is doing sub unit vaccines, for which there is very good evidence that portions of those sub units trigger disease enhancement.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼